AzTrials
AzTrials

AppetiteNCT02793297

Effects of Sourdough Fermented Rye Crisp Bread on Appetite and Postprandial Metabolic Responses

A study testing refined wheat crisp bread, sourdough fermented rye crisp bread and unfermented rye crisp bread in people with Appetite, run by Swedish University of Agricultural Sciences.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overall objective is to evaluate the impact of sourdough fermented crisp bread on effects on appetite and postprandial glucose and insulin responses. Beneficial effects on appetite and postprandial insulin responses have been observed, particularly for unfermented rye crisp breads in a previous study. Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Appetite
What is being tested?
refined wheat crisp bread, sourdough fermented rye crisp bread and unfermented rye crisp bread
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
No sites listed yet
Study dates
Jan 2015to Mar 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • BMI 18.5-30 kg/m2
  • fasting plasma glucose <6.0 mmol/L,
  • fasting serum insulin <11 mE/L
  • serum TSH <2.5 mIE/L
  • plasma LDL <5.3 mmol/L
  • fasting plasma triglycerides (p-TG) <1.8 mmol/L
  • habitual consumption of breakfast, lunch and dinner

Who cannot join

  • smokers
  • use of medications likely to affect appetite
  • medical conditions involving the gastrointestinal tract
  • gluten intolerance or food allergies
  • physical problems with eating
  • dieting or self-reported fluctuations in body weight of more than 10% three months prior to screening recent participation in a dietary study
  • pregnancy
  • lactation

About this study

Official title: Effects of Sourdough Fermented Rye Crisp Bread on Appetite and Postprandial Metabolic Responses: A Randomized Cross-over Trial

The overall objective is to evaluate the impact of sourdough fermented crisp bread on effects on appetite and postprandial glucose and insulin responses. Beneficial effects on appetite and postprandial insulin responses have been observed, particularly for unfermented rye crisp breads in a previous study. In the present study, the investigators evaluated how the intake of sourdough fermented rye crisp breads vs. unfermented rye crisp bread as well as a control refined wheat crisp bread product may affect self-rated appetite and postprandial insulin and glucose responses in healthy men and women in a meal-study. The investigators characterized intervention products with regards to microstructural and chemical features in order to elucidate underlying mechanisms for potential effects observed on appetite and postprandial metabolic responses.

Read the detailed description

Two commercial whole grain rye crisp breads processed differently (unfermented and sourdough fermented) and a refined wheat control product were tested in the study. The rye crisp bread products contained similar ingredients. All products provide similar amounts of available carbohydrates (about 30g). The total amount of test product is about 50-60g.

The specific primary aim of the study: To conduct a short-term breakfast intervention study in humans (n = 24) to compare the effect of 2 high-fiber rye crisp bread products processed in different ways (sourdough fermented or unfermented) and a refined wheat control crisp bread as part of a normal breakfast on self-rated appetite, postprandial glucose and insulin concentrations. Difference in post-prandial insulin response between products is the primary endpoint.

Secondary aim (conducted if significant effects in the primary endpoint have been demonstrated): To assess changes in hormones and their relation to self-perceived satiety, hunger and desire to eat and to differences in chemical and microstructural composition of the tested foods.

Conditions
Appetite
Being tested
refined wheat crisp bread, sourdough fermented rye crisp bread, unfermented rye crisp bread

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • refined wheat crisp breadOther

    Refined wheat crisp bread (52 g) was served as part of a regular breakfast together with margarine (15 g), cheese (20 mg), coffee/tea (150 mL), and juice (150 mL). The amount of crisp bread was adjusted so that all arms provided a similar amount of available carbohydrate (35 g).

  • sourdough fermented rye crisp breadOther

    Sourdough fermented rye crisp bread (59.4 g) was served as part of a regular breakfast together with margarine (15 g), cheese (20 mg), coffee/tea (150 mL), and juice (150 mL). The amount of crisp bread was adjusted so that all arms provided a similar amount of available carbohydrate (35 g).

  • unfermented rye crisp breadOther

    Unfermented rye crisp bread (59.8 g) was served as part of a regular breakfast together with margarine (15 g), cheese (20 mg), coffee/tea (150 mL), and juice (150 mL). The amount of crisp bread was adjusted so that all arms provided a similar amount of available carbohydrate (35 g).

Study groups in NCT02793297
Study groupRoleWhat they receive
refined wheat crisp breadExperimentalrefined wheat crisp bread was served as part of a complete standardized breakfast
Receives: Other: refined wheat crisp bread
sourdough fermented rye crisp breadExperimentalSourdough fermented rye crisp bread was served as part of a complete standardized breakfast
Receives: Other: sourdough fermented rye crisp bread
unfermented rye crisp breadExperimentalUnfermented rye crisp bread was served as part of a complete standardized breakfast
Receives: Other: unfermented rye crisp bread

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective appetite assessed using an electronic visual analogue scale

    Participants recorded their subjective sensation of fullness and hunger using an electronic visual analogue scale

    Measured: 360 min after breakfast

Secondary outcomes (3)
  1. Glucose

    Plasma levels

    Measured: 230 minutes after breakfast

  2. insulin

    Plasma levels

    Measured: 230 minutes after breakfast

  3. GLP-1

    Plasma levels

    Measured: 230 minutes after breakfast

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jun 2016 (estimated)
  2. Study startJan 2015
  3. Primary completionMar 2016
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02793297
Sponsor's protocol ID
Barilla2
Status last verified
Jun 2016
First submitted
29 May 2016
Last updated
9 Jun 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing refined wheat crisp bread, sourdough fermented rye crisp bread and unfermented rye crisp bread in people with Appetite, run by Swedish University of Agricultural Sciences.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 9 Jun 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective appetite assessed using an electronic visual analogue scale (time frame: 360 min after breakfast). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in